CRIS Current Research Information System

CONTI, FABIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.152
EU - Europa 1.936
AS - Asia 658
AF - Africa 151
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 5.904
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.140
GB - Regno Unito 568
SE - Svezia 356
CN - Cina 265
IT - Italia 256
VN - Vietnam 232
DE - Germania 231
IE - Irlanda 110
IN - India 101
RU - Federazione Russa 78
FR - Francia 71
TG - Togo 59
BE - Belgio 56
UA - Ucraina 54
EE - Estonia 51
ZA - Sudafrica 46
AT - Austria 34
JO - Giordania 34
CH - Svizzera 32
NG - Nigeria 24
CI - Costa d'Avorio 21
NL - Olanda 12
CA - Canada 11
IR - Iran 11
FI - Finlandia 7
CZ - Repubblica Ceca 3
LB - Libano 3
MK - Macedonia 3
PL - Polonia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AU - Australia 2
DK - Danimarca 2
HK - Hong Kong 2
HR - Croazia 2
JP - Giappone 2
PT - Portogallo 2
TR - Turchia 2
BD - Bangladesh 1
BG - Bulgaria 1
BR - Brasile 1
BY - Bielorussia 1
CL - Cile 1
EC - Ecuador 1
EG - Egitto 1
ES - Italia 1
GL - Groenlandia 1
ID - Indonesia 1
IL - Israele 1
IQ - Iraq 1
RO - Romania 1
SA - Arabia Saudita 1
SI - Slovenia 1
TW - Taiwan 1
Totale 5.904
Salva come PNG Salva come JPEG
Città #
Southend 533
Fairfield 529
Chandler 382
Houston 228
Woodbridge 218
Ashburn 198
Seattle 196
Wilmington 194
Ann Arbor 179
Dong Ket 154
Cambridge 152
Princeton 117
Dublin 110
Bologna 74
Nanjing 66
Lomé 59
Brussels 56
Westminster 53
Padova 43
Amman 34
San Diego 32
Berlin 30
Jinan 29
Bern 28
Bremen 27
Saint Petersburg 27
Vienna 27
Abeokuta 24
Beijing 24
Florence 24
Jacksonville 24
Turin 24
Abidjan 21
Boardman 20
Shenyang 20
Nanchang 18
Redmond 17
Dearborn 16
Tianjin 16
Medford 15
Falls Church 13
Changsha 11
Hebei 11
Haikou 9
Toronto 9
Des Moines 8
Milan 8
Chicago 7
Helsinki 7
London 7
Groningen 6
Guangzhou 6
Lanzhou 6
Los Angeles 6
Zhengzhou 6
Fuzhou 5
Jiaxing 5
Redwood City 5
Saint Louis 5
Amsterdam 4
Ardabil 4
Buffalo 4
Frankfurt Am Main 4
Hangzhou 4
Kunming 4
Leawood 4
Monmouth Junction 4
Moscow 4
Norwalk 4
Olalla 4
Paris 4
Rome 4
Sacramento 4
Stockholm 4
Benevento 3
Boydton 3
Ningbo 3
Provo 3
Skopje 3
Taizhou 3
Aachen 2
Andover 2
Cagliari 2
Cesena 2
Curno 2
Dallas 2
Imola 2
Mülheim 2
Osimo 2
Piandimeleto 2
Portomaggiore 2
Russi 2
San Francisco 2
Taiyuan 2
Tokyo 2
Washington 2
Zanjan 2
Atlanta 1
Azor 1
Baghdad 1
Totale 4.293
Salva come PNG Salva come JPEG
Nome #
Accuracy of elastography point quantification and steatosis influence on assessing liver fibrosis in patients with chronic hepatitis C 201
Accuracy of VirtualTouch Acoustic Radiation Force Impulse (ARFI) imaging for the diagnosis of cirrhosis during liver ultrasonography 188
Allocation priority in non urgent liver transplantation: an overview of proposed scoring systems 165
Alcohol and viral hepatitis: a mini-review. 153
Treating hepatitis C in the elderly: the future is near? 139
ANGPT2 and NOS3 polymorphisms and clinical outcome in advanced hepatocellular carcinoma patients receiving sorafenib 136
Hepatitis C Virus-related chronic liver disease in elderly patients: an Italian cross-sectional study. 135
Hepatocellular carcinoma risk assessment by the measurement of liver stiffness variations in HCV cirrhotics treated with direct acting antivirals 130
Biomarkers for the early diagnosis of bacterial infection and the surveillance of hepatocellular carcinoma in cirrhosis 126
A new approach to the use of α-fetoprotein as surveillance test for hepatocellular carcinoma in patients with cirrhosis. 126
Point quantification elastography in the evaluation of liver elasticity in healthy volunteers: a reliability study based on operator expertise 125
Vitamins in the treatment of chronic viral hepatitis. 120
Chronic hepatitis B: Are we close to a cure? 119
External Validation of Surrogate Indices of Fatty Liver in the General Population: the Bagnacavallo Study 117
Imbalance of Neutrophils and Lymphocyte Counts Can Be Predictive of Hepatocellular Carcinoma Occurrence in Hepatitis C-related Cirrhosis Treated With Direct-acting Antivirals 116
Hepatitis B virus reactivation among hepatitis C patients treated with direct-acting antiviral therapies in routine clinical practice 116
Secondary prophylaxis of hepatocellular carcinoma: the comparison of direct-acting antivirals with pegylated interferon and untreated cohort 115
Treatment with direct acting antiviral agents-based regimen in HCV patients with advanced liver disease: Analysis of an Italian multicenter observational study 115
DAAs treatment in HCV recurrence after liver transplantation: Clinical usefulness of non-invasive methods 113
Direct acting antivirals for the treatment of elderly patients with HCV advanced disease in the real life practice 113
Monofocal hepatocellular carcinoma: How much does size matter? 113
Correlation Between Renal Cortical Stiffness and Histological Determinants by Point Shear-Wave Elastography in Patients With Kidney Transplantation 112
null 107
DAAs treatment in hepatitis C virus recurrence after Liver Transplantation: clinical usefulness of non-invasive methods 107
Hepatitis C virus (HCV) infection in elderly patients: A multicenter Italian cross-sectional study 103
Deregulation of microRNA expression in peripheral blood mononuclear cells from patients with HCV-related malignancies 102
Reinfusion of highly purified CD133+ bone marrow-derived stem/progenitor cells in patients with end-stage liver disease: a phase I clinical trial 101
DIAGNOSTIC ACCURACY OF LIVER AND SPLEEN STIFFNESS MEASUREMENT FOR PORTAL HYPERTENSION USING BIDIMENSIONAL SHEAR WEAVE ELASTOGRAPHY 100
Recalibrating survival prediction among patients receiving trans‐arterial chemoembolization for hepatocellular carcinoma 99
Serum hepatitis B core-related antigen is an effective tool to categorize patients with HBeAg-negative chronic hepatitis B 97
null 96
Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: Predictive role in HCC development in cirrhotic patients 95
Imaging features of microvascular invasion in hepatocellular carcinoma developed after direct-acting antiviral therapy in HCV-related cirrhosis 93
null 92
Bile salt export pump deficiency disease: Two novel, late onset, ABCB11 mutations identified by next generation sequencing 92
A New Two-Dimensional Shear Wave Elastography for Noninvasive Assessment of Liver Fibrosis in Healthy Subjects and in Patients with Chronic Liver Disease - Eine neue zweidimensionale Shear-Wave-Elastografie zur nicht-invasiven Beurteilung der Leberfibrose bei Gesunden und bei Patienten mit chronischer Lebererkrankung 91
HCV clearance after direct-acting antivirals in patients with cirrhosis by stages of liver impairment: The ITAL-C network study 90
Transient elastography in healthy subjects and factors influencing liver stiffness in non-alcoholi fatty liver disease: an Italian community-based population study. 89
Liver AL amyloidosis as a possible cause of high liver stiffness values. 86
Hepatitis C virus eradication in the elderly: The challenge worth a long-life elixir? 84
Long-term outcomes of direct acting antivirals in post-transplant advanced hepatitis C virus recurrence and fibrosing cholestatic hepatitis 84
SP714SHEAR WAVE ELASTOGRAPHY IN KIDNEY TRANSPLANTATION: NONINVASIVE ALTERNATIVE TO ALLOGRAFT BIOPSY? 83
Liver grafts from hepatitis B surface antigen-positive donors: A review of the literature 82
THU-492 - Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: predictive role in hepatocellular carcinoma development in in cirrhotic patients 81
Relationship between hepatic hemodynamics assessed by Doppler ultrasound and liver stiffness. 80
The increase of Ribavirin dose improves sustained virological response in HCV-Genotype 1 patients with a partial response to PEG-Interferon and Ribavirin. 80
Predictors of hepatocellular carcinoma in HCV cirrhotic patients treated with direct acting antivirals 78
Could Inflammatory Indices and Metabolic Syndrome Predict the Risk of Cancer Development? Analysis from the Bagnacavallo Population Study 78
Liver Stiffness improvement in subjects with advanced chronic hepatitis C treated with direct antiviral agents. 76
Liver AL amyloidosis as a possible cause of high liver stiffness values. 75
null 70
Imaging Features of Microvascular Invasion in Hepatocellular Carcinoma Developed in HCV-Related Cirrhosis after Direct-Acting Antiviral Therapy. 69
Hepatitis C in the elderly: a multicenter cross-sectional study by the Italian Association for the Study of the Liver. 66
High efficacy of direct-acting anti-viral agents in hepatitis C virus-infected cirrhotic patients with successfully treated hepatocellular carcinoma 65
Tenofovir-induced Fanconi syndrome in a patient with chronic hepatitis B monoinfection. 64
Range of Normal Liver Stiffness and Factors Associated With Increased Stiffness Measurements in Apparently Healthy Individuals 57
Worsening of Serum Lipid Profile after Direct Acting Antiviral Treatment 53
IMPULSIONAL, POINT AND BIDIMENSIONAL SHEAR WAVE ELASTOMETRY FOR PORTAL HYPERTENSION: SAME STIFFNESS THRESHOLDS? 48
Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals 45
The changing scenario of hepatocellular carcinoma in Italy: an update 30
Safety and efficacy of direct-acting antivirals for the treatment of chronic hepatitis C in a real-world population aged 65 years and older 28
Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma 24
DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN HCV CIRRHOTIC PATIENTS TREATED WITH DIRECT ACTING ANTIVIRALS 23
Surveillance for hepatocellular carcinoma with a 3-months interval in "extremely high-risk" patients does not further improve survival 19
Totale 6.075
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.038
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.038
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019288 0 0 0 22 3 45 9 27 23 56 37 66
2019/20201.743 221 38 11 88 190 221 230 218 256 104 69 97
2020/2021848 152 75 37 18 9 33 21 45 86 59 39 274
2021/20221.307 117 40 65 81 100 55 19 78 35 128 388 201
2022/20231.513 134 212 70 231 97 128 54 78 262 37 125 85
2023/2024125 34 64 26 1 0 0 0 0 0 0 0 0
Totale 6.075